incretin hormone glp 1 The system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes What is the Incretin Effect

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection

Always consult your healthcare provider before combining medications to make sure the pairing is safe and effective for your needs

Safe discontinuation requires GP consultation to assess diabetes control, arrange monitoring, and establish alternative treatment if needed

Not a cure for MCAS, nor for anything else theyve been shown to help

Qingshan Zheng and Lujin Li designed the research

PlexusDx Precision Peptide Genetic Testing can predict your likely response timeline by analyzing your peptide-pathway genetics